---
document_datetime: 2023-09-21 17:06:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/orgalutran-epar-all-authorised-presentations_en.pdf
document_name: orgalutran-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7877568
conversion_datetime: 2025-12-29 20:36:20.532212
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength       | Pharmaceutical form    | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size             |
|------------------|-------------------|----------------|------------------------|---------------------------|----------------------------|---------------------------|-----------------------|
| EU/1/00/130/001  | Orgalutran        | 0.25 mg/0.5 mL | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 0.5 mL (0.5 mg/mL)        | 1 pre-filled syringe  |
| EU/1/00/130/002  | Orgalutran        | 0.25 mg/0.5 mL | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 0.5 mL (0.5 mg/mL)        | 5 pre-filled syringes |